Hans-Peter Rudolf

Hans-Peter Rudolf

Director/Board Member at
Phosphate Therapeutics Ltd.
60 year
Commercial Services
Consumer Services
Health Technology

Profile

Hans-Peter Rudolf is currently a Director at Phosphate Therapeutics Ltd. He previously worked as an Audit Partner at Ernst & Young LLP from 2003 to 2006, and as a Partner at Ernst & Young AG.
He was also the Head-Group Accounting at Bellefontaine Investments AG from 2011 to 2017, and an Audit Partner at Crowe LLP from 2006 to 2010.
From 2017 to 2020, he served as the Chief Financial Officer at Vicarius Pharma AG.
Rudolf holds an undergraduate degree from Cleveland State University and the University of Zurich.
He is currently the Chief Financial Officer at Shield Therapeutics Plc.

Hans-Peter Rudolf active positions

CompaniesPositionStart
Director/Board Member 2021-05-11

Former positions of Hans-Peter Rudolf

CompaniesPositionEnd
SHIELD THERAPEUTICS PLC Director of Finance/CFO 2023-10-19
Director of Finance/CFO 2020-03-31
Comptroller/Controller/Auditor 2017-03-31
Corporate Officer/Principal 2010-11-30
Corporate Officer/Principal 2006-06-30
See the detail of Hans-Peter Rudolf's experience

Training of Hans-Peter Rudolf

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

84

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Commercial Services

Consumer Services

Consumer Services

Commercial Services

Finance

Commercial Services

Health Technology

Health Technology

Commercial Services

  1. Stock Market
  2. Insiders
  3. Hans-Peter Rudolf